No Data
No Data
Assure Tech (Hangzhou)'s (SHSE:688075) Soft Earnings Are Actually Better Than They Appear
Anxu Biotech 2024 Semi-Annual Report
Summary of Anxu Biotech\'s 2024 Semi-Annual Report
Anxu Biology (688075.SH) released its performance in the first half of the year, with a net income of 0.115 billion yuan, a year-on-year decrease of 30.85%.
Anxu Bio (688075.SH) released its 2024 interim report, with revenue of 0.248 billion yuan for the company,...
Anxubio (688075.SH): net income in the first half of the year was 0.115 billion yuan, a year-on-year decrease of 30.85%.
On August 29, Axcy Biotech (688075.SH) released its semi-annual report. The company achieved revenue of 248.1567 million yuan, a 21.42% increase compared to the same period last year. The net income attributable to the owners of the parent company was 115.319 million yuan, a decrease of 30.85% compared to the same period last year. The net income attributable to the owners of the parent company after deducting non-recurring gains and losses was 18.885 million yuan, a decrease of 80.95% compared to the same period last year. At the end of the reporting period, the company's total assets reached 5796.4535 million yuan, a year-on-year increase of 0.12%; attributable to the owners of the parent company...
Anxubio (688075.SH): plans to launch a restricted stock incentive plan for 2024.
Gelonghui, August 29th, Anxusheng Biology (688075.SH) announced the 2024 Restricted Stock Incentive Plan, planning to grant 1.345 million restricted stocks to incentive recipients, accounting for approximately 1.06% of the company's total 127.082805 million shares at the time of the announcement of the draft incentive plan. Among them, the initial grant is 1.195 million shares, accounting for approximately 0.94% of the company's total shares at the time of the announcement of the draft incentive plan, and approximately 88.85% of the total equity to be granted under the incentive plan; the reserved grant is 0.15 million shares, accounting for approximately 0.12% of the company's total shares at the time of the announcement of the draft incentive plan.
No Data
No Data